Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-23 4:48 pm Purchase |
2023-05-12 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 3,661,518 8.300% |
447,932 (+13.94%) |
Filing History |
| 2023-04-04 08:59 am Purchase |
2023-03-29 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 3,213,586 7.400% |
552,432 (+20.76%) |
Filing History |
| 2023-03-07 06:01 am Purchase |
2023-03-03 | 13G | Inozyme Pharma, Inc. INZY |
Sphera Funds Management Ltd. | 2,096,258 5.190% |
2,096,258 (New Position) |
Filing History |
| 2023-02-14 4:09 pm Sale |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Venrock Healthcare Capital Partners II, L.P. | 3,867,749 9.300% |
-197,251 (-4.85%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Baker Bros. Advisors LP | 2,168,000 5.100% |
2,168,000 (New Position) |
Filing History |
| 2023-02-14 2:54 pm Purchase |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Rock Springs Capital Management LP | 3,086,027 7.640% |
633,390 (+25.82%) |
Filing History |
| 2023-02-14 08:38 am Unchanged |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Deep Track Capital, LP | 3,250,000 8.050% |
0 (Unchanged) |
Filing History |
| 2023-02-13 12:09 pm Purchase |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
CHI Advisors LLC | 2,204,876 5.460% |
2,204,876 (New Position) |
Filing History |
| 2023-02-10 10:03 am Sale |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Flynn James E | 0 0.000% |
-2,344,786 (Position Closed) |
Filing History |
| 2023-02-09 11:43 am Purchase |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
ADAGE CAPITAL PARTNERS GP LLC | 3,100,138 7.670% |
1,501,110 (+93.88%) |
Filing History |
| 2022-04-29 4:05 pm Purchase |
2022-04-19 | 13G | Inozyme Pharma, Inc. INZY |
Venrock Healthcare Capital Partners II, L.P. | 4,065,000 9.800% |
4,065,000 (New Position) |
Filing History |
| 2022-04-28 4:58 pm Purchase |
2022-04-19 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 2,661,154 6.600% |
1,070,000 (+67.25%) |
Filing History |
| 2022-04-28 4:50 pm Purchase |
2022-04-19 | 13D | Inozyme Pharma, Inc. INZY |
Longitude Capital Partners III LLC | 4,174,379 10.400% |
1,355,000 (+48.06%) |
Filing History |
| 2022-04-25 3:05 pm Purchase |
2022-04-14 | 13G | Inozyme Pharma, Inc. INZY |
Rock Springs Capital Management LP | 2,452,637 6.120% |
2,452,637 (New Position) |
Filing History |
| 2022-04-18 4:15 pm Purchase |
2022-04-14 | 13G | Inozyme Pharma, Inc. INZY |
Deep Track Capital, LP | 3,250,000 8.110% |
3,250,000 (New Position) |
Filing History |
| 2022-02-14 09:26 am Unchanged |
2021-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 1,591,154 6.700% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:37 pm Purchase |
2021-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Flynn James E | 2,344,786 9.910% |
1,194,487 (+103.84%) |
Filing History |
| 2022-02-10 09:22 am Purchase |
2021-12-31 | 13G | Inozyme Pharma, Inc. INZY |
ADAGE CAPITAL PARTNERS GP LLC | 1,599,028 6.760% |
310,356 (+24.08%) |
Filing History |
| 2022-02-07 1:58 pm Unchanged |
2021-12-31 | 13G | Inozyme Pharma, Inc. INZY |
New Enterprise Associates 15 L.P. | 2,437,689 10.300% |
0 (Unchanged) |
Filing History |
| 2021-11-15 4:35 pm Sale |
2021-11-15 | 13G | Inozyme Pharma, Inc. INZY |
RA Capital Management, L.P. | 0 0.000% |
-2,003,653 (Position Closed) |
Filing History |